Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.05

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2883)	2/11/2001 3:36:05 PM
From: Jibacoa	Read Replies (2) of 52153

RSTA: Conference scheduled for tomorrow at noon to discuss the paper being published in this week's issue of Nature. Back in December they announced deals with Glaxo and Agilent. In the last earnings report their loss was less and they reportedly have $4.90 cash/share. The insiders hold 77% and the institutions (which have been buying lately)17%(75% of float)The current ratio is 14.25 and there is a 9.8%(of float) short ratio = to approximately 4x average daily volume. Now with all those "pluses" why have so many insiders filed forms 144 with intentions to sell ? <g> biz.yahoo.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next